RTN4 3'-UTR insertion/deletion polymorphism and susceptibility to non-small cell lung cancer in Chinese Han population

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 13, 2014, Pages 5249-5252

  Lu, De Yi ^a   Mao, Xu Hua ^b   Zhou, Ying Hui ^a   Yan, Xiao Long ^c   Wang, Wei Ping ^a   Zheng, Ya Biao ^a   Xiao, Juan Juan ^a   Zhang, Ping ^a   Wang, Jian Guo ^a   Ashwani, Neetika ^a   Ding, Wei Liang ^b   Jiang, Hua ^d   Shang, Yan ^e   Wang, Ming Hua ^a  

^a SOOCHOW UNIVERSITY   (China)

^b YIXING PEOPLE S HOSPITAL   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d The Second People's Hospital of Xiangcheng District   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Non small cell lung cancer; Polymorphism; Rs34917480; RTN4; Susceptibility

Indexed keywords

3' UNTRANSLATED REGION; MYELIN PROTEIN; PROTEIN NOGO;

3' UNTRANSLATED REGION; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; MYELIN PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SEQUENCE DELETION;

EID: 84905366343     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.13.5249     Document Type: Article

References (24)

1. Acevedo L, Yu J, Erdjument-Bromage H, et al (2004). A new role for Nogo as a regulator of vascular remodeling. Nat Med, 10, 382-8.
2. Chen Y, Tang X, Cao X, Chen H, Zhang X (2006). Human Nogo-C overexpression induces HEK293 cell apoptosis via a mechanism that involves JNK-c-Jun pathway. Biochem Biophys Res Commun, 348, 923-8.
3. Chen YC, Lu DD, Cao XR, Zhang XR (2005). RTN4-C gene expression in hepatocellular carcinoma and its influence on SMMC7721 cell growth and apoptosis. Yi Chuan Xue Bao, 32, 891-7.
4. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM (2000). Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature, 403, 439-44.
5. Gray NK, Wickens M (1998). Control of translation initiation in animals. Annu Rev Cell Dev Biol, 14, 399-458.
6. Hecht SS (1999). Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst, 91, 1194-210.
7. Jansen RP (2001). mRNA localization: message on the move. Nat Rev Mol Cell Biol, 2, 247-56.
8. Kuang E, Wan Q, Li X, et al (2006). ER stress triggers apoptosis induced by Nogo-B/ASY overexpression. Exp Cell Res, 312, 1983-8.
9. Li Q, Qi B, Oka K, et al (2001). Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene, 20, 3929-36.
10. Liam CK, Leow HR, How SH, et al (2014). Epidermal growth factor receptor mutations in non-small cell lung cancers in a multiethnic Malaysian patient population. Asian Pac J Cancer Prev, 15, 321-6.
11. Mitchell P, Tollervey D (2001). mRNA turnover. Curr Opin Cell Biol, 13, 320-5.
12. Novak G, Kim D, Seeman P, Tallerico T (2002). Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res Mol Brain Res, 107, 183-9.
13. Novak G, Tallerico T (2006). Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3'-UTR. Brain Res, 1120, 161-71.
14. Oertle T, Huber C, van der Putten H, Schwab ME (2003). Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol, 325, 299-323.
15. Piao JM, Shin MH, Kim HN, et al (2013). Glutathione-S-transferase (GSTM1, GSTT1) null phenotypes and risk of lung cancer in a Korean population. Asian Pac J Cancer Prev, 14, 7165-9.
16. Sarkey JP, Chu M, McShane M, et al (2011). Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes. J Mol Cell Cardiol, 50, 1044-55.
17. Shi S, Zhou B, Wang Y, et al (2012). Genetic variation in RTN4 3'-UTR and susceptibility to cervical squamous cell carcinoma. DNA Cell Biol, 31, 1088-94.
18. Tagami S, Eguchi Y, Kinoshita M, Takeda M, Tsujimoto Y (2000). A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene, 19, 5736-46.
19. Tashiro K, Satoh A, Utsumi T, Chung C, Iwakiri Y (2013). Absence of Nogo-B (reticulon 4B) facilitates hepatic stellate cell apoptosis and diminishes hepatic fibrosis in mice. Am J Pathol, 182, 786-95.
20. Walsh PS, Metzger DA, Higuchi R (1991). Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques, 10, 506-13.
21. Watari A, Yutsudo M (2003). Multi-functional gene ASY/Nogo/RTN-X/RTN4: apoptosis, tumor suppression, and inhibition of neuronal regeneration. Apoptosis, 8, 5-9.
22. Yang J, Yu L, Bi AD, Zhao SY (2000). Assignment of the human reticulon 4 gene (RTN4) to chromosome 2p14→2p13 by radiation hybrid mapping. Cytogenet Cell Genet, 88, 101-2.
23. Zhang K, Bai P, Shi S, et al (2013). Association of genetic variations in RTN4 3'-UTR with risk of uterine leiomyomas. Pathol Oncol Res, 19, 475-9.
24. Zheng H, Xue S, Lian F, Wang YY (2011). A novel promising therapy for vein graft restenosis: overexpressed Nogo-B induces vascular smooth muscle cell apoptosis by activation of the JNK/p38 MAPK signaling pathway. Med Hypotheses, 77, 278-81.